Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano(University of Palermo), Alan Prem Kumar(National University of Singapore), Taha Merghoub(Cornell University), Saurabh Yadav(Harvard University), Tuan Zea Tan(National University Cancer Institute, Singapore), Ruby Yun‐Ju Huang(National University of Singapore), Jun Ishihara(Imperial College London), Hendrik Ungefroren(University Hospital Schleswig-Holstein), Bin‐Zhi Qian(Fudan University), Elena Okina(National University of Singapore), Mads Hald Andersen(Copenhagen University Hospital), Hiu Yan Lam(National University of Singapore), Gautam Sethi(National University of Singapore), Tao Shi(Anshan Hospital), Minah Kim(National Cancer Center), Kurt A. Schalper(Yale University), Elisa Giovannetti(University of Pisa), Tullia C. Bruno(University of Pittsburgh), Daniela Carbone(University of Palermo), Derek C. Radisky(Jacksonville College), Peng Luo(Zhujiang Hospital), Patrizia Diana(University of Palermo), E. Hui Clarissa Lee(Cornell University), Anjali P. Kusumbe(Nanyang Technological University), Matthew S. Davids(Dana-Farber Cancer Institute), Hui Li Ang(National University of Singapore), Simone Krebs(The University of Texas MD Anderson Cancer Center), Michelle Yi-Hui Yee(National Cancer Centre Singapore), Caroline Robert(Inserm), Lukas M. Carter(Memorial Sloan Kettering Cancer Center), Wen Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Dean G. Tang(Roswell Park Comprehensive Cancer Center), Hannah Lau(National University of Singapore), Jennifer Brown(Harvard University), Muthu K. Shanmugam(National University of Singapore), Xiao Zi Huang(National University of Singapore), Lina H. K. Lim(National University of Singapore)
Cited by 128
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k